Profil
William A.
Cavanagh worked as a Director at Haakon Ragde Foundation and as a Chief Scientific Officer at Sangretech Biomedical LLC.
He also worked at IsoRay Medical, Inc. as a Vice President-Research & Development from 2010 to 2016 and as a Chief Research & Development Officer at IsoRay, Inc. from 2019 to 2023.
He completed his undergraduate degree from the University of Portland.
Anciens postes connus de William Cavanagh
| Sociétés | Poste | Fin |
|---|---|---|
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Directeur Général | 14/02/2016 |
| IsoRay Medical, Inc. /Old/ | Directeur Technique/Scientifique/R&D | 03/03/2016 |
| Haakon Ragde Foundation | Directeur/Membre du Conseil | - |
| Sangretech Biomedical LLC | Directeur Technique/Scientifique/R&D | - |
Formation de William Cavanagh
| University of Portland | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| IsoRay Medical, Inc. /Old/ | Health Technology |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
| Sangretech Biomedical LLC | |
| Haakon Ragde Foundation |
